4//SEC Filing
EMIGH JAMES F 4
Accession 0001104659-21-029185
CIK 0000786947other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 4:11 PM ET
Size
8.8 KB
Accession
0001104659-21-029185
Insider Transaction Report
Form 4
EMIGH JAMES F
VP Marketing & Administration
Transactions
- Exercise/Conversion
Common Stock
2021-02-24$0.15/sh+20,000$3,020→ 481,592 total - Tax Payment
Common Stock
2021-02-24$0.40/sh−7,550$3,020→ 474,042 total - Exercise/Conversion
Stock options
2021-02-24−20,000→ 0 totalExercise: $0.15From: 2019-12-11Exp: 2023-12-11→ Common Stock (20,000 underlying)
Footnotes (5)
- [F1]Represents payment for exercise price.
- [F2]Exercise price is closing price of Issuer's common stock on December 11, 2018.
- [F3]Awarded under the Acura Pharmaceuticals Inc. 2016 Stock Option Plan
- [F4]100% of the shares underlying the options vest and are exercisable after one year on December 11, 2019
- [F5]Not Applicable.
Documents
Issuer
ACURA PHARMACEUTICALS, INC
CIK 0000786947
Entity typeother
IncorporatedNY
Related Parties
1- filerCIK 0001107934
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 4:11 PM ET
- Size
- 8.8 KB